Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 20651 - 20675 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Curcumin	Approved Investigational	ZNF589	51385	downregulated	Curcumin results in decreased expression of ZNF589 mRNA	3p21.31	A21795
Curcumin	Approved Investigational	ZNF823	55552	upregulated	Curcumin results in increased expression of ZNF823 mRNA	19p13.2	A21797
Cyanamide	Experimental	MITF	4286	downregulated	Cyanamide results in decreased expression of MITF mRNA	3p13	A20531
Cyanamide	Experimental	TYR	7299	downregulated	Cyanamide results in decreased expression of TYR mRNA	11q14.3	A20531
Cyclophosphamide	Approved Investigational	ABCB1	5243	upregulated	[Cyclophosphamide results in increased activity of NR1I2 protein] which results in increased expression of ABCB1 mRNA	7q21.12	A21862
Cyclophosphamide	Approved Investigational	ABHD3	171586	upregulated	Cyclophosphamide results in increased expression of ABHD3 mRNA	18q11.2	A21863
Cyclophosphamide	Approved Investigational	ACTB	60	downregulated	Cyclophosphamide results in decreased expression of ACTB mRNA	7p22.1	A21864
Cyclophosphamide	Approved Investigational	ALDH1A1	216	upregulated	Cyclophosphamide results in increased expression of ALDH1A1 mRNA	9q21.13	A21865
Cyclophosphamide	Approved Investigational	ALDH2	217	upregulated	Cyclophosphamide results in increased expression of ALDH2 mRNA	12q24.12	A21865
Cyclophosphamide	Approved Investigational	ALOX5AP	241	downregulated	Cyclophosphamide results in decreased expression of ALOX5AP mRNA	13q12.3	A21865
Cyclophosphamide	Approved Investigational	ANGPT1	284	upregulated	Cyclophosphamide results in increased expression of ANGPT1 mRNA	8q23.1	A21865
Cyclophosphamide	Approved Investigational	ARHGDIB	397	upregulated	Cyclophosphamide results in increased expression of ARHGDIB mRNA	12p12.3	A21863
Cyclophosphamide	Approved Investigational	ARHGEF26	26084	upregulated	Cyclophosphamide results in increased expression of ARHGEF26 mRNA	3q25.2	A20660
Cyclophosphamide	Approved Investigational	ASNS	440	downregulated	Cyclophosphamide metabolite results in decreased expression of ASNS mRNA	7q21.3	A20727
Cyclophosphamide	Approved Investigational	ATF5	22809	downregulated	Cyclophosphamide results in decreased expression of ATF5 mRNA	19q13.33	A21865
Cyclophosphamide	Approved Investigational	ATG3	64422	downregulated	Cyclophosphamide results in decreased expression of ATG3 mRNA	3q13.2	A20660
Cyclophosphamide	Approved Investigational	AXL	558	upregulated	Cyclophosphamide results in increased expression of AXL mRNA	19q13.2	A21863
Cyclophosphamide	Approved Investigational	B3GALNT2	148789	upregulated	Cyclophosphamide results in increased expression of B3GALNT2 mRNA	1q42.3	A21863
Cyclophosphamide	Approved Investigational	BCL2	596	upregulated	Cyclophosphamide results in increased expression of BCL2 mRNA	18q21.33	A21866
Cyclophosphamide	Approved Investigational	BCL6	604	downregulated	Cyclophosphamide metabolite results in decreased expression of BCL6 mRNA	3q27.3	A20727
Cyclophosphamide	Approved Investigational	BIK	638	downregulated	Cyclophosphamide results in decreased expression of BIK mRNA	22q13.2	A21865
Cyclophosphamide	Approved Investigational	BIRC3	330	downregulated	Cyclophosphamide metabolite results in decreased expression of BIRC3 mRNA	11q22.2	A20727
Cyclophosphamide	Approved Investigational	BPI	671	downregulated	Cyclophosphamide results in decreased expression of BPI mRNA	20q11.23	A21865
Cyclophosphamide	Approved Investigational	CA2	760	downregulated	Cyclophosphamide results in decreased expression of CA2 mRNA	8q21.2	A21865
Cyclophosphamide	Approved Investigational	CARS	833	downregulated	Cyclophosphamide metabolite results in decreased expression of CARS mRNA	11p15.4	A20727

Displaying entries 20651 - 20675 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability